Definitive Healthcare (NASDAQ:DH) Releases FY 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.360-0.380 for the period, compared to the consensus earnings per share estimate of 0.380. The company issued revenue guidance of $255.0 million-$261.0 million, compared to the consensus revenue estimate of $266.3 million. Definitive Healthcare also updated its Q2 2024 guidance to 0.080-0.090 EPS.

Wall Street Analyst Weigh In

DH has been the subject of several research analyst reports. Barclays decreased their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating for the company in a research note on Thursday. Stifel Nicolaus reduced their price objective on Definitive Healthcare from $11.00 to $9.50 and set a buy rating for the company in a research note on Wednesday. Canaccord Genuity Group lowered their target price on Definitive Healthcare from $10.00 to $8.00 and set a hold rating on the stock in a research report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price target on Definitive Healthcare from $10.00 to $7.00 and set a hold rating for the company in a research note on Thursday. Finally, Needham & Company LLC restated a hold rating on shares of Definitive Healthcare in a research note on Wednesday. Nine research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of Hold and an average target price of $9.94.

Definitive Healthcare Stock Performance

DH stock traded down $0.18 during midday trading on Thursday, reaching $5.17. 3,323,524 shares of the company’s stock traded hands, compared to its average volume of 643,916. Definitive Healthcare has a 52 week low of $4.38 and a 52 week high of $12.45. The company has a 50-day moving average price of $7.61 and a two-hundred day moving average price of $8.27. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. The firm has a market capitalization of $608.97 million, a PE ratio of -2.90, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. As a group, equities analysts anticipate that Definitive Healthcare will post 0.11 EPS for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.